Direct answer. A heart-healthy dietary pattern concerns what someone regularly eats and drinks. DASH, varied food-group guidance and nutrition support can inform clinical care, but kidney disease, heart failure, medicines, allergies and poor intake may require adaptation. A diet label is not a substitute for cardiac treatment or proof that a particular product prevents a heart attack. NHLBI following DASH, February 25, 2026.
- Food patterns concern repeated choices, not one miracle food.
- DASH guidance is care context; the original feeding trial received donated commercial food.
- Blood-pressure or cholesterol changes are different from heart-attack and survival outcomes.
- Kidney disease, poor appetite and heart-failure fluid advice need individual review.
- Warfarin does not require eliminating all green vegetables.
- Check actual medicines and ingredients before using potassium salt substitutes or supplements.
Evidence summary
| Question | Source role | Conclusion and confidence |
|---|---|---|
| Is a food pattern one branded product? | Current DASH and food-group education | No. Patterns allow varied ordinary foods and practical adaptation. |
| Does the original DASH trial supply an independent verdict here? | Original paper and documented donated study food | No. Tier 4/D for independence; methods context is separate. |
| Do marker changes prove heart-attack prevention? | Outcome distinction | No. Blood pressure, lipids, symptoms and events need separate evidence. |
| Can everyone increase potassium or restrict fluids? | Kidney and medicine safety context | No. The actual condition and treatment plan determine advice. |
| Should warfarin users avoid green vegetables? | Current national medicine precautions | No. Discuss consistency and important dietary changes with the treating service. |
Confidence is high in the need for condition-specific assessment and urgent attention to warning signs; recommendations are attributed clinical context, not independently certified treatment effects. The treatment section attributes clinical guidance; it does not certify the funding of every underlying intervention trial. Independent comparative outcome certainty and a supplement replacement regimen were not established by this focused review. A public institution or independent review cannot make a sponsored original trial financially independent.
DASH, varied food groups and culturally suitable patterns
A dietary pattern combines foods, preparation and eating habits over time. The dated NHS Eatwell guide describes the balance across a day or week rather than demanding identical proportions at every meal. The useful question is whether the overall pattern fits nutritional needs and the actual medical circumstances. NHS Eatwell guide, November 29, 2022; review overdue.
DASH means Dietary Approaches to Stop Hypertension. NHLBI describes a flexible pattern including vegetables, fruit, whole grains, beans, nuts, dairy and suitable protein sources. It does not require buying a branded plan. Food choices and amounts depend on needs; this guide gives no universal calorie, serving or sodium prescription. NHLBI following DASH, February 25, 2026.
A culturally suitable plan can use familiar ingredients. The current NHS balanced-diet page includes pulses and other protein choices. Discuss what is available, affordable and acceptable rather than assuming an unfamiliar menu is necessary. The numeric meat-portion anomaly on that page is excluded from this guide. NHS balanced diet, June 30, 2026; numeric meat anomaly excluded.
Food substitutions, fibre and the outcome actually measured
A pattern changes several exposures at once. Food sources, preparation, energy intake and medicines can all affect the assessment. Blood pressure and cholesterol are clinically relevant measurements, but a change in either is not identical to demonstrating fewer heart attacks or longer survival. Results should be described with the outcome actually measured.
NHLBI describes choosing unsaturated oils and limiting saturated-fat sources within a wider pattern. The dated NHS fat page identifies foods such as butter, ghee and coconut oil as saturated-fat sources. Substitution is a more useful discussion than assuming every fat must disappear or that adding oil cancels the rest of the meal. NHLBI heart-healthy foods, December 10, 2025; NHS types of fat, April 14, 2023; review overdue.
Fibre can come from varied whole grains, beans, vegetables and other foods. The current NHS source gives food examples. A food pattern, an isolated fibre product and a claim about cardiac events are different subjects. This guide does not transfer general nutrition advice into a benefit verdict for a capsule. NHS food sources of fibre, March 2, 2026.
DASH trial methods, donated food and current counselling context
The original DASH experiment randomized selected adults after a run-in, supplied study food, kept weight and sodium broadly similar and assessed blood pressure over eight intervention weeks. Blood-pressure staff were blinded to assignment. This helps interpret its design; it was not a long-term heart-attack study or an ordinary unsupervised home meal plan. Original 1997 DASH controlled-feeding trial; actual Harvard repository PDF.
That paper acknowledges NIH grants and commercial food donations. Under the strict independence standard used here, donated manufacturer or supplier products make its outcomes Tier 4/Grade D for financial independence. This does not itself determine whether the methods were good or the results wrong; it prevents using those outcomes as an independently certified efficacy verdict.
NHLBI currently presents DASH as a care framework. Clinical guidance can inform a discussion even when complete original-study finance has not been cleared. A public institute publishing the recommendation does not remove financial relationships in the trials underneath it. This article supplies no financially cleared percentage for preventing a cardiac event.
The 2026 ESC rehabilitation framework includes nutrition counselling adapted to the person and specialist dietetic support for complex needs. It also describes limited long-term outcome evidence for nutrition interventions within rehabilitation. Recommendation context and uncertainty are retained; its underlying outcome trials are not independently cleared here. Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections.
Shopping, preparation, salt sources and supplement claims
Start with actual shopping and cooking barriers. NHLBI discusses comparing foods, using herbs and preparing meals in ways that make a pattern practical. Frozen, fresh and suitable canned ingredients can serve different needs. A more expensive package or a heart symbol does not automatically supply a better overall diet. NHLBI living with DASH, February 25, 2026.
The dated NHS salt page identifies packaged foods, sauces and other everyday sources. It suggests seasoning alternatives. Reducing discretionary salt is different from choosing a potassium-based substitute, which may be unsuitable with kidney disease or particular medicines. Ask about the ingredient instead of assuming any reduced-sodium product is safe. NHS dietary salt, April 17, 2023; review overdue.
No detox tea, heart-support blend or concentrated antioxidant is independently established in this source set as a replacement for cardiac care. A medically prescribed nutrition supplement for poor intake has a different purpose from a product advertising heart-attack prevention. Bring labels and explain the reason for use before comparing products.
Food records, labels and fair evidence comparisons
A useful food record includes what was eaten, preparation, drinks, appetite and barriers. It can help the dietitian understand the starting point. It is not a diagnostic score or a test proving that a heart condition has resolved. Agree changes that fit the current findings instead of treating compliance with a diet name as the only outcome.
Food labels can help compare actual products. NHS guidance distinguishes information per standard quantity from information per portion; the stated portion may differ from what someone eats. Check ingredients and the amount consumed. One favourable number does not establish allergy safety, medicine compatibility or suitability for a whole day. NHS food labels, June 30, 2026.
Avoid comparing a short controlled feeding experiment with a long-term community programme as though they measured the same thing. Sustained eating habits, blood-pressure changes, hospital admissions and mortality need different assessments. Study finance, participants, adherence, duration and harms all belong beside a claimed benefit rather than behind a promotional headline.
Cardiac emergencies, allergy and inadequate intake
Food choices are not emergency treatment for concerning chest discomfort, breathlessness, sweating, nausea or spreading pain. Collapse or severe breathing difficulty requires an emergency response. A recent healthy meal, diet change or reassuring measurement is not a reason to wait. Use the local emergency service. NHLBI heart-attack symptoms, March24,2022.
Food allergy can cause severe swelling, breathing difficulty, confusion or faintness. Follow the prescribed emergency plan and seek emergency help. Nuts, fish or other foods suggested in a general eating pattern may be unsuitable for a particular person; a heart-health label does not override an allergy. NHS food allergy, August 20, 2026.
Poor intake, unintended weight loss, weakness or difficulty eating needs assessment. The dated NHS malnutrition source describes risk across ages and the need for support. A restrictive plan should not be praised simply because weight is falling; ask whether intake and function are adequate. No home BMI or weight-loss threshold is supplied. NHS malnutrition, May 23, 2023; review overdue.
Warfarin, grapefruit, potassium products and diuretic plans
Warfarin users can still eat green vegetables. The current NHS page advises discussing significant food changes and relevant products with the treating service. Vitamin K consistency and the actual anticoagulation plan matter; eliminating nutritious foods indiscriminately is not the instruction. Do not transfer warfarin precautions to every other anticoagulant. NHS warfarin, February 24, 2026; selected food precautions.
The same warfarin source identifies particular drinks and supplements for caution. Bring the exact product and ingredients. A smoothie, concentrated extract and ordinary food portion need not be equivalent exposures. Ask the anticoagulation service before a major change rather than choosing an internet dose adjustment. NHS warfarin, February 24, 2026; selected food precautions.
Grapefruit interactions depend on the actual statin and medicine list. NHS advice is to check suitability with a pharmacist or clinician. A blanket ban for every cholesterol medicine, or stopping the prescription because of one food, can misrepresent the issue. Use current local information for the prescribed product. NHS statins, May 5, 2026; exact food-combination review.
Furosemide advice depends on why it is prescribed, including the fluid plan and exact combinations. Potassium-increasing products require review. Do not independently add an electrolyte blend, force extra water or change a diuretic to accommodate a diet challenge. Ask the responsible clinician or pharmacist. NHS furosemide, July 7, 2026; selected hydration and interaction context.
Kidney disease, heart failure and individual nutrition needs
Kidney disease can change potassium, phosphorus, protein and fluid needs. NIDDK says there is no single meal plan for all CKD; needs can change with disease stage and dialysis. Ask the kidney team to coordinate recommendations with heart care. A generic high-potassium pattern is not automatic clearance. NIDDK adult CKD nutrition, January 2025; selected individual nutrition context.
NIDDK specifically cautions that some salt substitutes contain potassium. Review the ingredient list and clinical results with the team. This does not mean everyone with CKD must eliminate fruit, beans or nuts; restrictions and portions need an individual explanation rather than a universal forbidden-food list. NIDDK adult CKD nutrition, January 2025; selected individual nutrition context.
Heart failure can require a condition-specific fluid discussion. Worsening breathlessness, swelling or other deterioration should be reported rather than managed solely by food changes. Do not assume every heart patient needs the same fluid restriction, or that drinking less treats a new symptom safely. NHS heart failure, June 26, 2026; selected night-breathlessness context.
Preparing a dietitian review and coordinating advice
There is no personal diet dose here. Bring diagnoses, laboratory reports, medicines, supplements, allergies and an account of typical eating. Describe access to cooking, costs, religious or cultural needs, work patterns and appetite. Ask which changes matter first and who will review whether they remain appropriate.
An assessed plan should explain its purpose. Improving food variety, addressing an abnormal measurement, supporting adequate intake and managing a medicine interaction are different goals. Agree how progress and adverse symptoms are assessed. A commercial meal score should not replace the relevant clinical review or required monitoring.
Where several services give advice, request one coordinated explanation. A kidney recommendation, cardiac fluid plan and diabetes medicine schedule may affect the same meal. Do not independently resolve conflicting leaflets by choosing the most restrictive option. Ask the teams or dietitian to state what applies now and when to reassess.
Nutrient mechanisms versus proven human cardiac outcomes
Cell, animal and nutrient-pathway findings can suggest mechanisms. They cannot establish a human food-product dose, reverse a valve lesion or prove fewer cardiovascular events. Biomarkers and patient outcomes are separate. Manufacturer-funded or supplied-product studies remain Tier 4/Grade D for independence even when a review or public guideline includes them. The original DASH paper is used for methods and financial context only.
Funding and source roles
Who paid for the evidence?
Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.
View 23 more funding disclosures
This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.
Dietary patterns have no single corporate owner. Food suppliers, meal programmes, supplements and commercial tests have separate interests. NIH and NHS public institutional finance does not clear every underlying trial; society income does not establish a particular guideline payment. Supplier donations in the original trial are explicitly identified and efficacy excluded from the independent verdict.
The clinical subject has no single corporate owner; medicines, devices and supplements have separate commercial ownership and financial interests. Medicines, diagnostics, devices, procedures and marketed supplements create different revenue incentives. This describes financial interests rather than misconduct. Funding tier evaluates proximity to the subject; A–D credibility assesses transparency, accuracy incentives and remaining uncertainty. An unresolved link stays unresolved, and a provisional public-information label does not clear the trials behind it.
| Source | Funding / backers | Country / jurisdiction | Independence | Credibility / incentives / gaps |
|---|---|---|---|---|
| NHLBI heart-healthy foods, December 10, 2025 | NIH/HHS appropriations and gift route. Exact page/author/study finance unclosed. | United States; NHLBI, Bethesda, Maryland. Underlying trials have separate jurisdictions. | Tier 1 public education route, provisional; underlying efficacy independence unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general food-pattern context. Numerical benefit, personal nutrient targets and complete trial clearance excluded. Role: General food-pattern context, not an independent event-effect estimate. |
| NHLBI following DASH, February 25, 2026 | NIH/HHS appropriations and gift route. Exact page/author/study finance unclosed. | United States; NHLBI, Bethesda, Maryland. Underlying trials have separate jurisdictions. | Tier 1 public education route, provisional; underlying efficacy independence unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general food-pattern context. Numerical benefit, personal nutrient targets and complete trial clearance excluded. Role: DASH definition and flexible food categories. |
| NHLBI living with DASH, February 25, 2026 | NIH/HHS appropriations and gift route. Exact page/author/study finance unclosed. | United States; NHLBI, Bethesda, Maryland. Underlying trials have separate jurisdictions. | Tier 1 public education route, provisional; underlying efficacy independence unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general food-pattern context. Numerical benefit, personal nutrient targets and complete trial clearance excluded. Role: Shopping and preparation context; fixed potassium targets excluded. |
| NHS Eatwell guide, November 29, 2022; review overdue | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual dated body read; scheduled review overdue. Simplification and author/trial-finance gaps limit use to selected definitions or precautions. Targets and prognostic estimates excluded. Role: Dated food-group pattern and adaptation context. |
| NHS balanced diet, June 30, 2026; numeric meat anomaly excluded | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual June 2026 body read. A numeric red-meat portion statement is anomalous and excluded; selected variety/protein-source context retained. No outcome estimate or complete study clearance. Role: Selected current variety/protein-source context; meat anomaly excluded. |
| NHS food labels, June 30, 2026 | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general education with page/author/trial gaps. No numerical benefit or personal intake regimen. Role: Current portion and ingredient-label interpretation. |
| NHS types of fat, April 14, 2023; review overdue | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual dated body read; scheduled review overdue. Simplification and author/trial-finance gaps limit use to selected definitions or precautions. Targets and prognostic estimates excluded. Role: Dated saturated/unsaturated food substitutions. |
| NHS dietary salt, April 17, 2023; review overdue | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual dated body read; scheduled review overdue. Simplification and author/trial-finance gaps limit use to selected definitions or precautions. Targets and prognostic estimates excluded. Role: Dated salt-source and seasoning context. |
| NHS food sources of fibre, March 2, 2026 | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general education with page/author/trial gaps. No numerical benefit or personal intake regimen. Role: Current varied food sources, not supplement efficacy. |
| NHS warfarin, February 24, 2026; selected food precautions | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general education with page/author/trial gaps. No numerical benefit or personal intake regimen. Role: Current food-change and exact-product precautions. |
| NHS statins, May 5, 2026; exact food-combination review | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general education with page/author/trial gaps. No numerical benefit or personal intake regimen. Role: Current medicine-specific food-interaction review. |
| NHS malnutrition, May 23, 2023; review overdue | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | C provisional — actual dated body read; scheduled review overdue. Simplification and author/trial-finance gaps limit use to selected definitions or precautions. Targets and prognostic estimates excluded. Role: Dated poor-intake assessment context. |
| NHS food allergy, August 20, 2026 | National NHS accounts and editorial policy. Page, contributor and original-study financing unclosed. | United Kingdom; national NHS England, Leeds contact; local medicine and care rules differ. | Tier 1 public education route, provisional; original efficacy finance unclassified. | B provisional — actual dated body read. Public-care accuracy incentive; general education with page/author/trial gaps. No numerical benefit or personal intake regimen. Role: Current food-allergy and emergency recognition. |
| NIDDK adult CKD nutrition, January 2025; selected individual nutrition context | NIDDK federal enacted-budget table and permitted gifts. Page allocation, individual reviewer and original-trial finances unclosed. | United States; NIDDK, Bethesda, Maryland; complete study/backer jurisdictions unresolved. | Tier 1 public education route, provisional; individual and original-trial finance unclassified. | B provisional — actual January 2025 nutrition body read; no named individual credited on this body. Public-care accuracy incentive and simplified advice; targets, licence claims and outcome estimates excluded. Role: Current individualized kidney nutrition and potassium-substitute precautions. |
| NHS heart failure, June 26, 2026; selected night-breathlessness context | National NHS England 2025–26 accounts and editorial policy. Specific allocation, contributors and underlying-trial finance unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | B provisional — actual dated body read selectively. Public-care accuracy incentive; simplified local pathways, full trial funding unclosed. No home threshold, survival estimate or driving-law transfer. Role: Current deterioration and assessed fluid context. |
| NHS furosemide, July 7, 2026; selected hydration and interaction context | National NHS own accounts and editorial policy. Contributor, original-study and exact page funding unclosed. | United Kingdom; national NHS England, Leeds contact. Full contributor and study jurisdictions unclosed. | Tier 1 national public education, provisional; original-trial independence unclassified. | C provisional — actual July 7, 2026 selected safety body read; fluid advice and exact combinations need individualized review. Thresholds, dose changes, rarity reassurance and universal fluid volumes excluded. Role: Current exact medicine/fluid and potassium-product precautions. |
| NHLBI heart-attack symptoms, March24,2022 | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 1 public education provisionally; donation route and page-specific chain unresolved. | C provisional — actual2022/2024 original body read selectively. Public educational accuracy incentive; dated generalizations and full source/underlying-trial financial gaps. Relative sex/race outcome claims, surgical-menopause simplification, blanket HRT harm, fixed risk tools/ages, symptom-severity reassurance and dose instructions excluded. Selected attributed warning signs, diagnostic purpose and care questions only. Role: Emergency cardiac symptom recognition. |
| Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections | Preamble states ESC development funding without healthcare-industry involvement; society income includes industry partnerships. Separate author report and trial chains not retrieved. | France; ESC association, Sophia Antipolis; multinational clinical panel. | Tier 2 professional framework, provisional; full author/trial finance unclassified. | C provisional — actual selected August 2026 nutrition-counselling and long-term uncertainty passages read, alongside development preamble. Professional/reputation incentives; separate author report and source-trial finance unclosed. No effect estimate, universal diet or commercial product endorsement. Role: Selected 2026 nutrition-counselling context and long-term uncertainty. |
| ESC actual current institutional income model; annual 2026 PDF unavailable | Actual institutional page lists membership, scientific events, publication/education/accreditation and life-science/medtech partnership income. Statutory-audit claim is self-reported. Annual2026 PDF exceeded access limit; totals and page allocations not verified. | France; ESC European Heart House, Sophia Antipolis. Multinational ESC/ERA collaboration; full study/supplier jurisdictions unresolved. | Tier 3 institutional financial self-report. | B provisional for actual stated income routes; institution has commercial and professional incentives, complete donor/contract and publication allocations unclosed. Financial role only. Role: Actual society income and industry routes. |
| Original 1997 DASH controlled-feeding trial; actual Harvard repository PDF | Original printed p1123: NIH/NHLBI, minority-health and research-resource grants; food donated by Best Foods, Campbell’s, Coca-Cola Foods, Comstock, Dannon, Dole, Heinz, Harris Teeter, Hershey, Lifelines, McCormick, Nabisco, Ocean Spray, Procter & Gamble, Quaker, Ralston, Sunkist, Vandenbergh and Wawona. Exact contributions and current ownership unclosed. | US multicentre research; original lists NHLBI sponsor Bethesda. Harvard Cambridge, Massachusetts hosts the original; it is not assumed the funder. Complete supplier jurisdictions unclosed. | Tier 4 manufacturer/supplier donated study products, despite public grants. | D for financial independence. Actual nine-page repository PDF read; feeding, randomization and blinded blood-pressure assessment checked separately. Short marker study, selected population and provided meals limit transfer. Outcomes excluded from independent verdict. Role: Original methods and financial boundary only; efficacy excluded. |
| NHS England actual audited2025–26 accounts | National NHS England: actual2025–26 audited accounts documents DHSC grant-in-aid as principal finance plus service, education/research and other consolidated income. content policy rejects advertising/corporate sponsorship. Exact page budget, contributor and underlying-trial financial chain unresolved; provider trusts have separate finances. | United Kingdom; national England patient information, institutional contact Leeds; local services and driving rules vary. | Tier 3 institutional financial self-report. | B provisional for actual statutory financial channels; no page/trial allocation or complete donor chain. |
| NIDDK actual May2024 FAQ: appropriation, gift authority and location | Actual May2024 FAQ states congressional appropriations and authority to accept voluntary conditional/unconditional gifts and bequests, with conflict review. Named/current gifts and exact page allocations not disclosed. | United States; NIDDK/NIH/HHS Bethesda, Maryland, with a Phoenix, Arizona branch. Underlying trial and gift-source jurisdictions unclosed. | Tier 3 institutional financial self-report. | B provisional for actual stated appropriation/gift/location routes or budget columns; self-report, named donors and publication allocations unresolved. Financial provenance only. Role: Actual appropriation/gift authority, not page-specific donations. |
| NIDDK actual FY2027 congressional justification,21 pages; FY2026 enacted column read | Actual21-page FY2027 justification distinguishes FY2025 final, FY2026 enacted and FY2027 request columns; FY2026 discretionary and mandatory type1-diabetes funding are separate. Proposed FY2027 amounts are not current receipts. | United States; NIDDK/NIH/HHS Bethesda, Maryland, with a Phoenix, Arizona branch. Underlying trial and gift-source jurisdictions unclosed. | Tier 3 institutional financial self-report. | B provisional for actual stated appropriation/gift/location routes or budget columns; self-report, named donors and publication allocations unresolved. Financial provenance only. Role: Actual FY2026 enacted column, separate from FY2027 request. |
| NHLBI budget | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 3 institutional financial self-disclosure. | B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only. |
| NHLBI Gift Fund | US federal appropriations; separate Gift Fund accepts donations and bequests, including support for public health information. Budget route; Gift authority. Actual donors, page allocation and underlying trial finances unresolved. | United States; NIH/NHLBI, Bethesda, Maryland; federal jurisdiction. | Tier 3 institutional financial self-disclosure. | B provisional. Direct public financial policy, with legal accountability; actual gift donors and allocations not audited. Financial provenance only. |
| NHS national website funding policy | DHSC funds the national NHS website; its policy states no advertising or corporate sponsorship. Named authors, page-level budget and full underlying trial conflicts unresolved. | United Kingdom; England national public-information service. Other jurisdictions have different services. | Tier 3 editorial and financial self-disclosure. | B provisional. Explicit funding policy; actual individual declarations and implementation not audited. Financial provenance only. |
Frequently asked questions
Does heart-healthy eating mean one branded diet? No. An appropriate pattern can use varied ordinary foods and practical adaptation.
Does DASH replace blood-pressure medicine? No prescription change is supplied; the clinician reviews the actual condition and measurements.
Does this prove a Mediterranean or DASH product prevents heart attacks? No branded-product or independently cleared event-effect verdict is established.
Must warfarin users avoid all green vegetables? No. Discuss consistency and significant food changes with the treating service.
Are potassium salt substitutes safe for everyone? No. Kidney disease and medicines can change suitability.
Is losing weight always a good sign? No. Unintended loss or poor intake needs assessment.
Sources and funding notes
- NHLBI heart-healthy foods, December 10, 2025 — General food-pattern context, not an independent event-effect estimate.
- NHLBI following DASH, February 25, 2026 — DASH definition and flexible food categories.
- NHLBI living with DASH, February 25, 2026 — Shopping and preparation context; fixed potassium targets excluded.
- NHS Eatwell guide, November 29, 2022; review overdue — Dated food-group pattern and adaptation context.
- NHS balanced diet, June 30, 2026; numeric meat anomaly excluded — Selected current variety/protein-source context; meat anomaly excluded.
- NHS food labels, June 30, 2026 — Current portion and ingredient-label interpretation.
- NHS types of fat, April 14, 2023; review overdue — Dated saturated/unsaturated food substitutions.
- NHS dietary salt, April 17, 2023; review overdue — Dated salt-source and seasoning context.
- NHS food sources of fibre, March 2, 2026 — Current varied food sources, not supplement efficacy.
- NHS warfarin, February 24, 2026; selected food precautions — Current food-change and exact-product precautions.
- NHS statins, May 5, 2026; exact food-combination review — Current medicine-specific food-interaction review.
- NHS malnutrition, May 23, 2023; review overdue — Dated poor-intake assessment context.
- NHS food allergy, August 20, 2026 — Current food-allergy and emergency recognition.
- NIDDK adult CKD nutrition, January 2025; selected individual nutrition context — Current individualized kidney nutrition and potassium-substitute precautions.
- NHS heart failure, June 26, 2026; selected night-breathlessness context — Current deterioration and assessed fluid context.
- NHS furosemide, July 7, 2026; selected hydration and interaction context — Current exact medicine/fluid and potassium-product precautions.
- NHLBI heart-attack symptoms, March24,2022 — Emergency cardiac symptom recognition.
- Actual ESC cardiac rehabilitation guideline, August 2026, DOI ehag099; selected sections — Selected 2026 nutrition-counselling context and long-term uncertainty.
- ESC actual current institutional income model; annual 2026 PDF unavailable — Actual society income and industry routes.
- Original 1997 DASH controlled-feeding trial; actual Harvard repository PDF — Original methods and financial boundary only; efficacy excluded.
- NHS England actual audited2025–26 accounts — National institutional finance, not food-trial allocation.
- NIDDK actual May2024 FAQ: appropriation, gift authority and location — Actual appropriation/gift authority, not page-specific donations.
- NIDDK actual FY2027 congressional justification,21 pages; FY2026 enacted column read — Actual FY2026 enacted column, separate from FY2027 request.
- NHLBI budget — Financial provenance only.
- NHLBI Gift Fund — Financial provenance only.
- NHS national website funding policy — Financial provenance only.
The selected clinical originals and institutional financial sources were opened, with access-limited author reports and corrections identified explicitly. Actual December2025 NHLBI food and February2026 following/living-with-DASH bodies read. Personal calories, sodium, potassium and serving regimens excluded. Actual NHS June2026 label/balanced bodies read; balanced page numeric red-meat portion anomaly excluded. Actual March2026 fibre, February2026 warfarin, May2026 statin, August2026 allergy and July2026 furosemide selected bodies read. November2022 Eatwell, April2023 fats/salt and May2023 malnutrition bodies read with overdue reviews explicit. Actual January2025 NIDDK CKD nutrition body read; no named reviewer on that body, no series-reviewer payment inferred. Actual August2026 ESC nutrition-counselling/uncertainty passages and previously opened finance/preamble used; full separate declarations and source-trial chains unclosed. Actual original1997 DASH nine-page PDF downloaded read-only from observed Harvard repository link because direct journal access was restricted; printedp1123 documents NIH grants and commercial food donations. Trial outcome estimates excluded under Tier4/D supplier-product rule; randomization, provided-food design and marker-duration limits read separately. Complete historical supplier ownership/contribution amounts remain unclosed. No personal diet, nutrient, medicine or fluid algorithm. Guidance, classification, emergency education and independent efficacy are distinct source roles. A full systematic review, complete society donor audit and author-by-author clearance of original treatment trials were not completed.
Last reviewed: October 4, 2026. Educational information, not a diagnosis or personal treatment plan. Use your local emergency service for an emergency.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.